Biltmore Family Office, LLC Amgen Inc Transaction History

Biltmore Family Office, LLC

$566 Million
Q3 2024

A detailed history of Biltmore Family Office, LLC transactions in Amgen Inc stock. As of the latest transaction made, Biltmore Family Office, LLC holds 3,024 shares of AMGN stock, worth $887,664. This represents 0.17% of its overall portfolio holdings.

Number of Shares

3,024

Previous 2,891 4.6%

Holding current value

$887,664

Previous $903,000 7.86%

% of portfolio

0.17%

Previous 0.17%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$309.38 - $337.38 $41,147 - $44,871	133 Added 4.6%	3,024 $974,000
Q2 2024 Aug 07, 2024	BUY	$262.75 - $319.31 $157,650 - $191,586	600 Added 26.19%	2,891 $903,000
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $11,292 - $13,631	-42 Reduced 1.8%	2,291 $651,000
Q2 2023 Aug 07, 2023	BUY	$214.27 - $253.37 $157,916 - $186,733	737 Added 46.18%	2,333 $517,000
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $11,063 - $13,484	49 Added 3.17%	1,596 $385,000
Q4 2022 Feb 07, 2023	SELL	$229.03 - $291.01 $13,283 - $16,878	-58 Reduced 3.61%	1,547 $406,000
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $27,384 - $30,884	-122 Reduced 7.06%	1,605 $362,000
Q2 2022 Aug 04, 2022	SELL	$230.71 - $256.74 $57,677 - $64,185	-250 Reduced 12.65%	1,727 $420,000
Q1 2022 May 12, 2022	SELL	$219.27 - $242.57 $36,398 - $40,266	-166 Reduced 7.75%	1,977 $478,000
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $82,734 - $94,681	416 Added 24.09%	2,143 $482,000
Q2 2021 Jul 30, 2021	SELL	$233.58 - $259.14 $24,525 - $27,209	-105 Reduced 5.73%	1,727 $421,000
Q1 2021 May 12, 2021	SELL	$221.91 - $258.6 $221,910 - $258,600	-1,000 Reduced 35.31%	1,832 $456,000
Q4 2020 Feb 09, 2021	BUY	$216.38 - $257.67 $41,112 - $48,957	190 Added 7.19%	2,832 $651,000
Q1 2020 May 08, 2020	SELL	$182.24 - $241.7 $14,032 - $18,610	-77 Reduced 2.83%	2,642 $536,000
Q4 2019 Feb 05, 2020	BUY	$189.21 - $243.2 $14,569 - $18,726	77 Added 2.91%	2,719 $655,000
Q3 2019 Oct 16, 2019	BUY	$174.11 - $208.62 $165,752 - $198,606	952 Added 56.33%	2,642 $511,000
Q2 2019 Jul 31, 2019	SELL	$166.7 - $195.41 $11,669 - $13,678	-70 Reduced 3.98%	1,690 $311,000
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $8,563 - $9,996	48 Added 2.8%	1,760 $343,000
Q2 2018 Jul 17, 2018	SELL	$166.05 - $186.51 $161,898 - $181,847	-975 Reduced 36.29%	1,712 $316,000
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $147,404 - $172,260	870 Added 47.88%	2,687 $458,000
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $306,691 - $342,668	1,817	1,817 $316,000

Others Institutions Holding AMGN

# of Institutions

3,095

Shares Held

405M

Call Options Held

7.57M

Put Options Held

7.12M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $157B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Biltmore Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Biltmore Family Office, LLC with notifications on news.

Account

Biltmore Family Office, LLC Amgen Inc Transaction History